Discover · The Research Behind It
Effects of fecal microbiota transplantation on glycemic and lipid profiles in overweight or obese patients with metabolic disorders: a systematic review and meta-analysis — Zhang et al., Front Endocrinol (Lausanne) 2025
Last checked
- Free
- Worldwide
- Research paper
- Reading
- Online
- Published in
- Frontiers in Endocrinology, 2025
- Evidence
- Moderate
- Cost
- Free.
What is this paper about?
Eleven randomised trials (320 adults with overweight or obesity plus metabolic syndrome, type 2 diabetes or related problems) tested faecal microbiota transplant (FMT) from healthy lean donors. Pooled, FMT did not significantly change body mass index (−0.65; P = 0.07), insulin resistance (HOMA-IR −0.64; P = 0.06) or HbA1c (P = 0.74), on low-certainty evidence. The authors conclude its true metabolic benefit remains uncertain.
Why is it in the directory?
Explains that faecal transplant is not an established treatment for weight or blood sugar; context for the FMT clinic directory in chapter 01 and the regulated FMT services in chapter 15, whose proven use is recurrent C. difficile infection.
Is it free to read?
Systematic review and meta-analysis — 11 randomised trials, 320 adults with overweight or obesity and metabolic disease (PROSPERO-registered). Moderate evidence. Front Endocrinol (Lausanne) 2025;16:1737543. DOI 10.3389/fendo.2025.1737543. Free full text in PubMed Central (PMC12745229) — open access, CC BY 4.0.
About the paper
- Authors
- Zhang Y, Cao J, Wang Y, et al.
- Published in
- Front Endocrinol (Lausanne) 2025;16:1737543
- Kind of study
- Systematic review and meta-analysis — 11 randomised trials, 320 adults with overweight or obesity and metabolic disease (PROSPERO-registered)
- Strength of evidence
- Moderate — good studies, but fewer of them or with some limits
- Free to read
- CC BY 4.0
Good to know
- Low-certainty evidence from small trials with different donors and methods; an earlier meta-analysis found small short-term HbA1c and insulin improvements but no weight loss.
Where it sits in the directory
Listed under “The Microbiome & Chronic Disease” in chapter 17 of the directory, The Research Behind It, with 15 other listings in the same category.
Similar listings
Also in the directory, with why each one is here.
- Fecal transplantation for treatment of inflammatory bowel disease — Imdad et al., Cochrane Database Syst Rev 2023
Also a free research paper available worldwide, also for clinicians, in the same category.
Twelve randomised trials (550 people) tested faecal microbiota transplant (FMT) for inflammatory bowel disease.
- Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression — Sharpton et al., Am J Clin Nutr 2019
Also a free research paper available worldwide, also for clinicians, in the same category.
Twenty-one randomised trials (1,252 people with non-alcoholic fatty liver disease, now called MASLD) tested probiotics or synbiotics (probiotics plus prebiotic fibre)…
- AGA FMT National Registry
A free tool or directory for people in the United States, also for clinicians, listed under “FMT & Microbiome Therapy” in Medical Professional Directories.
The American Gastroenterological Association's national registry for fecal microbiota transplantation (FMT) and other gut microbial therapies.
- TGA — Faecal microbiota transplant products: how they are regulated (Australia)
A free guide or book for people in Australia, also for clinicians, listed under “Regulated Microbiome Therapies” in Gut Health & the Microbiome.
Australia's medicines regulator explains how FMT has been regulated since 1 July 2021: most products are Class 1 (made and used in the same hospital) or Class 2 (on the…
- Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation — Valabhji et al., Lancet Diabetes Endocrinol 2024
Also a free research paper available worldwide, also for clinicians, listed under “Metabolic Therapies” in the same chapter.
The NHS offered adults aged 18–65 diagnosed with type 2 diabetes in the last 6 years a 12-month programme starting with 12 weeks of total diet replacement (soups and…
- University of Birmingham — Microbiome Treatment Centre, MHRA-licensed FMT (United Kingdom)
A free guide or book for people in the United Kingdom, also for clinicians, listed under “Regulated Microbiome Therapies” in Gut Health & the Microbiome.
The UK's first MHRA-licensed facility producing faecal microbiota transplant (FMT) under Good Manufacturing Practice, set up in 2017 inside the University of…
This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.